Cel Sci Corporation (CVM)

[GD]

Very interesting DD from mastervp on stockwits:

" Attempts of direct administration of cytokine mixtures, known under
a name of “multikine”, leaded to the controversial results" inferring the "robust benefit".

Sentiment shows that multikine cytokine therapy had a "robust benefit only
in a subset of patients" -- this is similar to the aintree leak which
suggested it was 'difficult' to know which subset of patients would benefit from the drug.

https://stocktwits.com/message/256425578

To me, now it is 100% clear NWBO and CVM are in the same camp
the PIII results are data mined in strong subgroup data to fight
for FDA's approval, I am going to watch with no positions of NWBO
and CVM now to see what happens after results, good luck to CVM longs!!!